Daniel Goldstein, MD
Adult Reconstructive Orthopaedic Surgery · Mount Laurel, NJNPI 1750542270
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,085 of the $3,349 with a category attached, or 62.3%. 20 manufacturers reported payments, led by Amgen at 26.3% of the total. Reporting peaked in 2019 at $1,103 and has fallen 75.0% since, to $276 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NJ, where the typical reported total is $8,051.
Across 70 payments — averaging $47.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$880
- Johnson & Johnson$655
- Stryker$323
- Globus Medical$217
- Zimmer Biomet$208
- Smith+Nephew$176
- plus $888 from 14 others
What the payments were for
- Speaking & faculty fees$80024%
- Travel & lodging$46414%
- Food & beverage$2,08562%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $880 |
| Johnson & Johnson(2 entities) | 6 | $655 |
| Stryker | 7 | $323 |
| Globus Medical | 4 | $217 |
| Zimmer Biomet | 4 | $208 |
| Smith+Nephew | 2 | $176 |
| Abiomed | 1 | $126 |
| Medical Device Business Services, Inc. | 5 | $117 |
| Pacira Therapeutics, Inc. | 6 | $108 |
| Heraeus Medical, LLC. | 9 | $107 |
| Orthalign Inc | 1 | $93 |
| Ferring Pharmaceuticals Inc. | 5 | $76 |
| Dynasplint Systems Inc. | 1 | $70 |
| Fidia Pharma USA Inc. | 3 | $54 |
| Pfizer | 3 | $47 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Solventum Corporation | 1 | $19 |
| Baxter Healthcare | 1 | $17 |
| Medtronic | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,349 in reported general payments places this provider in the 25th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.
See all adult reconstructive orthopaedic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 135 | $5,040 |
| Meloxicam | 70 | $439 |
| Methylprednisolone | 26 | $126 |
| Amoxicillin | 38 | $100 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $50 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Mount Laurel
- Atul KamathManasquan$4M
- Alfred TriaSomerset$582K
- John DundonHackettstown$573K
- Ismar DizdarevicRidgewood$368K
- David FeldmanEnglewood$335K
- Mark PizzurroRidgewood$239K
- Jeffrey LearyNew Providence$148K
- Timothy HendersonWayne$140K
- Anthony CostaEatontown$95K
- Gregory RoehrigManasquan$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.